Who We Are
- Predictive Therapeutics is wholly owned subsidiary of Predictive Technology Group, Inc., a publicly traded entity with it’s stock symbol, PRED which traded on the OTC.
What We Do
- Predictive Therapeutics (“PRx”) revolutionizes the treatment of serious and debilitating diseases through the commercialization of novel therapeutics leveraged by proprietary gene-based companion diagnostics.
- PRx has developed and/or acquired a number of proprietary technologies that open a window into the origin of human disease and the role that genes and their related proteins play in the disease’s onset and progression.
- PRx uses this information as the cornerstone in the development of new diagnostics that assess a person’s risk of disease and therapeutic products designed to effectively prevent and/or treat the disease.
